Allergan beats earnings estimates on strong sales of Botox, Restasis

(Reuters) - Allergan Plc's third-quarter profit topped Wall Street forecasts on Wednesday, as the drugmaker sold more Botox and benefited from strength in its eye care business that houses dry-eye medicine Restasis.